|
7,394
|
| 72525 |
LRP1
|
|
interacts (colocalizes) with
|
LNPEP
|
in primary rat
adipocytes
|
|
19864425
|
Diabetes mellitus, type II
Insulin resistance
|
|
12,035
|
| 118092 |
Angiotensin IV
|
|
increases_activity of
|
LNPEP
|
|
| 118093 |
LNPEP
|
|
is_expressed_in
|
brain
|
|
| 118095 |
LNPEP
|
|
is_expressed_in
|
adrenal gland
|
|
| 118096 |
LNPEP
|
|
is_expressed_in
|
kidney
|
|
| 118098 |
LNPEP
|
|
is_expressed_in
|
lung
|
|
| 118099 |
LNPEP
|
|
is_expressed_in
|
liver
|
|
| 118101 |
LNPEP
|
|
is_expressed_in
|
heart
|
|
| 118102 |
LNPEP
|
|
affects_activity of
|
learning or memory
|
|
| 118130 |
Angiotensin (3-7)
|
|
increases_activity of
|
LNPEP
|
in brain, in kidney
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
|
12,039
|
| 118109 |
Angiotensin IV
|
|
interacts (colocalizes) with
|
LNPEP
|
|
|
11707427
|
Cardiovascular disease
|
|
12,056
|
| 118335 |
Angiotensin IV
|
|
increases_activity of
|
LNPEP
|
|
| 118337 |
LVV-hemorphin-7
|
|
interacts (colocalizes) with
|
LNPEP
|
|
| 118338 |
LNPEP
|
|
is localized in
|
SLC2A4 vesicles
|
|
| 118344 |
Angiotensin (3-7)
|
|
interacts (colocalizes) with
|
LNPEP
|
|
|
19065996
|
Diabetes mellitus, type II
Insulin resistance
|
|
12,057
|
| 118227 |
Angiotensin IV
|
|
increases_activity of
|
LNPEP
|
|
| 118247 |
LNPEP
|
|
decreases_activity of
|
apoptotic process
|
|
| 118248 |
LNPEP
|
|
affects_activity of
|
phosphatidylinositol 3-kinase signaling
|
|
| 118249 |
LNPEP
|
|
affects_activity of
|
TOR signaling
|
|
| 118251 |
LNPEP
|
|
decreases_activity of
|
inflammatory response
|
|
|
27038740
|
Cardiovascular disease
|
|
12,058
|
| 118252 |
LNPEP
|
|
increases_activity of
|
vasodilation
|
|
|
9493859
|
Cardiovascular disease
|
|
12,089
|
| 118752 |
LNPEP
|
|
increases_expression of
|
SERPINE1
|
in aortic endothelial cells
|
|
7593643
|
Cardiovascular disease
|
|
12,194
|
| 119796 |
Angiotensin IV
|
|
increases_activity of
|
LNPEP
|
|
| 119797 |
LNPEP
|
|
decreases_activity of
|
neurodegeneration
|
|
|
32127770
|
Neurodegenerative disorder
|
|
12,344
|
| 120838 |
atherosclerotic lesions
|
|
decreases_expression of
|
LNPEP
|
|
|
27754866
|
Cardiovascular disease
|
|
12,354
|
| 120931 |
LNPEP
|
|
decreases_activity of
|
abnormal spatial reference memory
|
|
|
10234025
|
Neurological
|
|
14,067
|
| 132965 |
Angiotensin IV
|
|
increases_activity of
|
LNPEP
|
|
| 132973 |
Angiotensin IV
|
|
increases_activity of
|
LNPEP
|
|
| 132976 |
Angiotensin II
|
|
increases_activity of
|
LNPEP
|
|
|
33169633
|
COVID-19
|
|
14,143
|
| 133668 |
Angiotensin (1-9)
|
|
increases_expression of
|
LNPEP
|
in LNCaP cells, in PC3 cells
|
| 133670 |
Angiotensin (3-7)
|
|
increases_expression of
|
LNPEP
|
in PC3 cells
|
|
32872192
|
Prostate cancer
|
|
14,146
|
| 133714 |
LNPEP
|
|
is_expressed_in
|
esophageal epithelium
|
|
|
24452037
|
Gastroesophageal reflux
|
|
14,159
|
| 133789 |
LNPEP
|
|
is_expressed_in
|
brain
|
|
| 133812 |
LNPEP
|
|
decreases_quantity of
|
Met-enkephalin
|
|
| 133819 |
LNPEP
|
|
decreases_quantity of
|
Dynorphin
|
|
| 133820 |
LNPEP
|
|
decreases_quantity of
|
Oxytocin
|
|
| 133821 |
LNPEP
|
|
decreases_quantity of
|
Arg-vasopressin
|
|
| 133822 |
LNPEP
|
|
decreases_quantity of
|
Lysyl-bradykinin
|
|
| 133823 |
LNPEP
|
|
decreases_quantity of
|
Neurokinin A
|
|
| 133824 |
LNPEP
|
|
decreases_quantity of
|
Somatostatin
|
|
| 133825 |
LNPEP
|
|
decreases_quantity of
|
Neuromedin B
|
|
| 133826 |
LNPEP
|
|
decreases_quantity of
|
Cholecystokinin-8
|
|
| 133873 |
LNPEP
|
|
affects_activity of
|
dendrite arborization
|
|
|
23213621
|
Parkinson disease
|
|
14,168
|
| 133891 |
LNPEP
|
|
is_expressed_in
|
H4 neuroglioma cell
|
|
|
17900533
|
Neurodegenerative disorder
|
|
14,183
|
| 133972 |
LNPEP
|
|
increases_activity of
|
synaptic transmission, cholinergic
|
in hippocampus
|
|
11249971
|
Neurodegenerative disorder
|
|
14,200
|
| 134067 |
LNPEP
|
|
increases_activity of
|
NF-kappaB complex
|
in vascular smooth muscle cells
|
|
15831814
|
Cardiovascular disease
|
|
14,203
|
| 134076 |
LNPEP
|
|
decreases_quantity of
|
Arg-vasopressin
|
in adipocytes, in skeletal muscle
|
| 134081 |
LNPEP
|
|
decreases_quantity of
|
Oxytocin
|
|
| 134082 |
LNPEP
|
NOT |
decreases_quantity of
|
Angiotensin IV
|
|
|
17684103
|
Cardiovascular disease
|
|
14,224
|
| 134264 |
hyperglycemia
|
|
increases_expression of
|
LNPEP
|
|
|
23942780
|
Diabetes mellitus, type II
Insulin resistance
|
|
14,227
|
| 134266 |
LNPEP
|
|
is_expressed_in
|
pineal gland
|
|
|
30222958
|
Diabetes mellitus, type II
Insulin resistance
|
|
14,231
|
| 134372 |
Angiotensin IV
|
|
increases_activity of
|
LNPEP
|
|
|
30978131
|
Cardiovascular disease
|
|
14,423
|
| 136135 |
LNPEP
|
|
decreases_quantity of
|
Sodium:potassium-exchanging ATPase complex
|
in LLC-PK1 kidney cell line; after stimulation with angiotensin IV
|
| 136138 |
Angiotensin IV
|
|
increases_activity of
|
LNPEP
|
in LLC-PK1 kidney cell line
|
| 136145 |
LNPEP
|
|
decreases_activity of
|
Sodium:potassium-exchanging ATPase complex
|
in LLC-PK1 kidney cell line; after stimulation with angiotensin IV
|
|
17634404
|
Renal
|
CIDeRplus